卫宁健康1月30日获融资买入1.58亿元，融资余额13.05亿元

Core Viewpoint - On January 30, 2023, Weining Health experienced a decline of 4.58% in stock price, with a trading volume of 1.711 billion yuan, indicating market volatility and investor sentiment concerns [1]. Financing Summary - On January 30, Weining Health had a financing buy-in amount of 158 million yuan, while financing repayment was 190 million yuan, resulting in a net financing outflow of 31.94 million yuan [1]. - The total financing and securities balance for Weining Health reached 1.31 billion yuan, with the financing balance accounting for 5.33% of the circulating market value, which is above the 50th percentile level over the past year, indicating a relatively high financing level [1]. - In terms of securities lending, 55,500 shares were repaid, and 100,100 shares were sold short on January 30, with a total selling amount of approximately 1.1061 million yuan, while the remaining securities lending balance was 379,200 shares, valued at 4.1906 million yuan, which is below the 40th percentile level over the past year, indicating a lower level of short selling [1]. Business Performance Summary - As of January 20, 2023, Weining Health had 122,900 shareholders, an increase of 4.22% from the previous period, while the average circulating shares per person decreased by 4.01% to 14,847 shares [2]. - For the period from January to September 2025, Weining Health reported a revenue of 1.296 billion yuan, a year-on-year decrease of 32.27%, and a net profit attributable to shareholders of -241 million yuan, reflecting a significant year-on-year decline of 256.10% [2]. Dividend and Shareholding Summary - Since its A-share listing, Weining Health has distributed a total of 455 million yuan in dividends, with 97.226 million yuan distributed over the past three years [3]. - As of September 30, 2025, among the top ten circulating shareholders, Huabao Zhongzheng Medical ETF held 50.0772 million shares, a decrease of 8.6961 million shares from the previous period, while E Fund Growth Enterprise Board ETF held 38.7261 million shares, down by 6.5376 million shares [3]. - Noan Growth Mixed A became a new entrant among the top ten circulating shareholders with a holding of 16.891 million shares, while Zhaoshang Advantage Enterprise Mixed A exited the list [3].